Search research articles
Contact Us
Filters
Showing results (111-120 of 141) with videos related to
Page
of 15
Sort By:
Plos One
|
June 27, 2017
Enhanced light microscopy visualization of virus particles from Zika virus to filamentous ebolaviruses
George G Daaboul, David S Freedman, Steven M Scherr, et al.
Annals of Internal Medicine
|
March 5, 2004
Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose
Stephanos J Hadziyannis, Hoel Sette, Timothy R Morgan, et al.
Cancer
|
January 19, 2021
Expenditures among young adults with acute lymphoblastic leukemia by site of care
Julie A Wolfson, Smita Bhatia, Jill Ginsberg, et al.
Respiratory Research
|
May 31, 2020
Once-daily single-inhaler versus twice-daily multiple-inhaler triple therapy in patients with COPD: lung function and health status results from two replicate randomized controlled trials
Gary T Ferguson, Nicola Brown, Chris Compton, et al.
Journal of Women'S Health (2002)
|
April 22, 2021
Sex-Based Differences in COVID-19 Outcomes
Astha Tejpal, Eugenia Gianos, Jane Cerise, et al.
Journal of Viral Hepatitis
|
April 14, 2019
Efficacy and safety of ombitasvir/paritaprevir/ritonavir and dasabuvir with low-dose ribavirin in patients with chronic hepatitis C virus genotype 1a infection without cirrhosis
Fred Poordad, Shahriar Sedghi, Paul J Pockros, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
July 29, 2014
Management of acute loss of asthma control in the yellow zone: a practice parameter
Chitra Dinakar, John Oppenheimer, Jay Portnoy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 22, 2015
Modernizing Eligibility Criteria for Molecularly Driven Trials
Edward S Kim, David Bernstein, Susan G Hilsenbeck, et al.
The Science of the Total Environment
|
March 14, 2019
Using high-resolution residential greenspace measures in an urban environment to assess risks of allergy outcomes in children
Rebecca Gernes, Cole Brokamp, Glenn E Rice, et al.
Hepatology (Baltimore, Md.)
|
January 23, 2016
Simeprevir plus sofosbuvir (12 and 8 weeks) in hepatitis C virus genotype 1-infected patients without cirrhosis: OPTIMIST-1, a phase 3, randomized study
Paul Kwo, Norman Gitlin, Ronald Nahass, et al.
Page
of 15
Search research articles
Search
Showing results (111-120 of 141) with videos related to
Sort By:
Page
of 15
Plos One
|
June 27, 2017
Enhanced light microscopy visualization of virus particles from Zika virus to filamentous ebolaviruses
George G Daaboul, David S Freedman, Steven M Scherr, et al.
Annals of Internal Medicine
|
March 5, 2004
Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose
Stephanos J Hadziyannis, Hoel Sette, Timothy R Morgan, et al.
Cancer
|
January 19, 2021
Expenditures among young adults with acute lymphoblastic leukemia by site of care
Julie A Wolfson, Smita Bhatia, Jill Ginsberg, et al.
Respiratory Research
|
May 31, 2020
Once-daily single-inhaler versus twice-daily multiple-inhaler triple therapy in patients with COPD: lung function and health status results from two replicate randomized controlled trials
Gary T Ferguson, Nicola Brown, Chris Compton, et al.
Journal of Women'S Health (2002)
|
April 22, 2021
Sex-Based Differences in COVID-19 Outcomes
Astha Tejpal, Eugenia Gianos, Jane Cerise, et al.
Journal of Viral Hepatitis
|
April 14, 2019
Efficacy and safety of ombitasvir/paritaprevir/ritonavir and dasabuvir with low-dose ribavirin in patients with chronic hepatitis C virus genotype 1a infection without cirrhosis
Fred Poordad, Shahriar Sedghi, Paul J Pockros, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology
|
July 29, 2014
Management of acute loss of asthma control in the yellow zone: a practice parameter
Chitra Dinakar, John Oppenheimer, Jay Portnoy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 22, 2015
Modernizing Eligibility Criteria for Molecularly Driven Trials
Edward S Kim, David Bernstein, Susan G Hilsenbeck, et al.
The Science of the Total Environment
|
March 14, 2019
Using high-resolution residential greenspace measures in an urban environment to assess risks of allergy outcomes in children
Rebecca Gernes, Cole Brokamp, Glenn E Rice, et al.
Hepatology (Baltimore, Md.)
|
January 23, 2016
Simeprevir plus sofosbuvir (12 and 8 weeks) in hepatitis C virus genotype 1-infected patients without cirrhosis: OPTIMIST-1, a phase 3, randomized study
Paul Kwo, Norman Gitlin, Ronald Nahass, et al.
Page
of 15